Educational content only. Not medical advice, and no doctor-patient relationship is created. Read the medical disclaimer
OVERVIEW
Why we built a place where clinicians can disagree in public, show their evidence, and help patients tell opinion from proof.
Featuring: Dr. Farhan Tahir, MD
Peptides discussed: All peptides
Peptide medicine is moving faster than the evidence behind it. Every week a new ranking, protocol or bold claim circulates online. Some of it is thoughtful clinical experience. Some of it is marketing. Patients are left to sort it out on their own.
What the Roundtable is
The Peptide Roundtable is our home for academic conversation. It has three parts:
Youthful Pep Talk: recorded conversations with physicians, researchers and pharmacists about specific peptides.
Perspectives: short commentary and updates when new trials or FDA decisions land.
Opinion vs. Evidence: side-by-side looks at what experts believe and what the published data shows.
Our ground rules
Every claim points to a source, or is clearly labeled as opinion.
Guests disclose conflicts of interest.
No dosing, no protocols and no product endorsements.
Respectful disagreement is welcome. That is the point.
Opinions here belong to the speaker. Our evidence grades on each peptide page stay the same no matter who is talking.
Academic discussion for education only. Not medical advice, not a recommendation to use any product, and no dosing is discussed. Opinions belong to the speakers. Talk with your own licensed clinician.
This is an academic discussion for education only and is not medical advice. Watching it does not create a doctor-patient relationship. Talk to your licensed provider before making any health decision.